You are here

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2

Authors

  • Giulia Pellizzari St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Olivier Martinez Immunoengineering Group, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Silvia Crescioli St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Robert Page Immunoengineering Group, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Ashley Di Meo Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Silvia Mele St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Giulia Chiaruttini St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Jan Hoinka Computational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Ihor Batruch Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Ioannis Prassas Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Melanie Grandits St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Jacobo López-Abente St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Eva Bugallo-Blanco Immunoengineering Group, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Malcolm Ward Aulesa Biosciences Ltd, Shefford, England, UK PubMed articlesGoogle scholar articles
  • Heather J Bax St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Elise French St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Anthony Cheung St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Sara Lombardi St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK School of Cancer and Pharmaceutical Sciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Mariangela Figini Biomarker Unit, Dipartimento di Ricerca Applicata e Sviluppo Tecnologico (DRAST), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy PubMed articlesGoogle scholar articles
  • Katie E Lacy St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Eleftherios P Diamandis Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Debra H Josephs St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, England, UK PubMed articlesGoogle scholar articles
  • James Spicer School of Cancer and Pharmaceutical Sciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles
  • Sophie Papa Immunoengineering Group, King's College London, London, England, UK Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, England, UK PubMed articlesGoogle scholar articles
  • Sophia N Karagiannis St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, London, England, UK PubMed articlesGoogle scholar articles

Citation

Pellizzari G, Martinez O, Crescioli S, et al
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2
Journal for ImmunoTherapy of Cancer 2021;9:e002140. doi: 10.1136/jitc-2020-002140
Online issue publication 
February 24, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.